RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Jill Bargonetti to Antineoplastic Agents, Hormonal

Back to Details
This is a "connection" page, showing publications Jill Bargonetti has written about Antineoplastic Agents, Hormonal.
Jill Bargonetti
Connection Strength
0.147
Antineoplastic Agents, Hormonal
  1. Kundu N, Brekman A, Kim JY, Xiao G, Gao C, Bargonetti J. Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway. Oncotarget. 2017 Jul 18; 8(29):47916-47930.
    View in: PubMed
    Score: 0.147
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support